The diabetic injection that helps with weight loss: what you actually need to know

Is this medicine for people with diabetes, or can anyone with weight concerns use it?

This is probably the question sitting at the back of your mind, so it is the right place to start. Tirzepatide was first studied and approved for type 2 diabetes management, but the same mechanism that lowers blood sugar (slowing how quickly the stomach empties and signalling fullness to the brain) also reduces how much people eat. When researchers ran dedicated weight-management trials in adults without diabetes, the results were substantial. In SURMOUNT-1, participants without diabetes who received the highest tirzepatide dose lost an average of around 20–21% of their body weight over 72 weeks, as published in the New England Journal of Medicine.

The UK licensing followed the evidence. Mounjaro (tirzepatide) holds a licence for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea. A diabetes diagnosis is not required. Wegovy (semaglutide) is licensed on the same basis. So the phrase "diabetic injection" is historically accurate but a little misleading today, these medicines now have a life of their own in weight management, separate from their diabetes origins, and if you want to understand more about how a diabetic injection can help with weight loss in people who do not have diabetes, that page explains the background clearly. You can read more about which injections are used for weight loss and how their licences differ.

What does matter is that a prescriber reviews your complete health picture. Certain conditions (a history of pancreatitis, specific thyroid tumours, or some gastrointestinal disorders) require careful discussion before starting. The assessment exists to protect you, not as a formality.

What does the clinical assessment actually look at?

If you are thinking of starting one of these injections, the consultation is more detailed than a BMI check. A prescriber considers your current weight, your BMI, any weight-related conditions you have, other medicines you are taking, and your medical history. That last point matters more than people sometimes expect.

If you are already prescribed medication for type 2 diabetes (particularly insulin or a sulphonylurea) adding a GLP-1 or dual-agonist injection can increase the risk of low blood sugar. Your diabetes team would normally coordinate that change. Similarly, if you take an oral contraceptive, the NHS England guidance on weight-management injections advises adding a non-oral method of contraception for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, because slowed gastric emptying can reduce how reliably the pill is absorbed.

HRT users may be advised to consider transdermal options (patches or gels) for the same reason, and anyone due for surgery should tell their anaesthetist they are on a GLP-1 or tirzepatide injection. None of these are reasons to avoid treatment, they are the kind of detail a good prescriber works through with you. If you want a broader look at injections used for weight loss and how they compare, that page covers the landscape.

The consultation at nume is reviewed personally by a GPhC-registered Independent Prescriber the same day you submit it. A real clinician reads your answers; your case is not processed by software.

Are there people for whom these injections are not suitable?

Yes, and it is worth being clear about this. Neither tirzepatide nor semaglutide is recommended during pregnancy. If you are breastfeeding, trying to conceive, or planning a pregnancy in the near future, these medicines are not suitable, and a prescriber will decline to issue a prescription in those circumstances. Women who could become pregnant are advised to use reliable contraception throughout treatment and for a wash-out period afterwards before trying to conceive, the exact duration depends on the medicine and should be confirmed with your prescriber.

The medicines are also not licensed for anyone under 18. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 should not use them. Pancreatitis history requires careful review. In January 2026 the MHRA issued a Drug Safety Update drawing attention to acute pancreatitis as a known infrequent but serious risk, severe or persistent stomach pain that spreads to the back, with or without vomiting, warrants urgent medical attention. You can report any suspected side effects through the MHRA Yellow Card scheme.

Most adults whose BMI and health history fall within the licensed criteria will be assessed as suitable, but eligibility is a clinical judgement, not a box to tick. The page on weight-loss injections for people without diabetes goes into further detail on who can access treatment privately in the UK.

How do you actually go about getting started?

We understand that if you have been waiting on an NHS list, or your GP has not been able to refer you yet, reaching this page might have taken a while. That frustration is real, and it is common. Private treatment through a regulated UK pharmacy does not require a referral or a waiting list. The route is a clinical consultation, a same-day prescriber review, and (once approved) dispatch the same day for next-working-day delivery.

The process at nume starts with a free consultation that you complete online. It is reviewed the same day by one of our GPhC-registered prescribers, who checks your health history, current medicines, BMI, and eligibility. Photo-ID verification and live weight confirmation are part of the process. If you are approved, your treatment is dispatched in plain, unbranded packaging via DPD. Everything (consultation, prescription, delivery, and 7-day aftercare) is included in one price, with no subscription and no automatic renewals.

If you have questions before you begin, the FAQ page covers the most common ones, and if you have come across the Mujra weight loss injection and want to know how it fits into the wider range of options, that page sets out the details. For a fuller picture of the treatment options available, the weight loss treatments page sets everything out clearly. And if you are ready to check whether you qualify, you can check your eligibility now with no obligation.